Rovalpituzumab is a humanized monoclonal antibody against delta-like protein 3 (DLL3). Rovalpituzumab can be used in the synthesis of antibody-drug conjugate (ADC), Rovalpituzumab Tesirine. Rovalpituzumab has activity against small cell lung cancer (SCLC).
Purity:
>98.0%
CAS Number:
[1613313-01-1]
* VAT and and shipping costs not included. Errors and price changes excepted
